U.S. eHealth Market Size, Share & Trends Analysis Report By Product (Telemedicine, Health Information Systems, mHealth, ePharmacy), By End Use (Providers, Payers, Patients), And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
U.S. eHealth Market Growth & Trends
The U.S. eHealth market size is expected t%li%reach USD 376.6 billion by 2030, registering a CAGR of 17.6% from 2024 t%li%2030, according t%li%a new report by Grand View Research, Inc. The eHealth market is driven by several key factors, including ongoing technological advancements like telemedicine and AI, increased demand for healthcare services, accelerated adoption due t%li%the COVID-19 pandemic, supportive regulatory frameworks, a shift towards patient-centric care models, the cost-effectiveness of digital solutions, data analytics for patient health management, and improved global connectivity. Furthermore, e-prescription is a notable driver of the eHealth market due t%li%its ability t%li%streamline medication management and improve patient safety. It enables healthcare providers t%li%electronically send accurate and legible prescriptions t%li%pharmacies, reducing errors and enhancing efficiency.
E-prescription systems als%li%facilitate better medication adherence by providing patients convenient access t%li%their prescribed medications and dosage instructions, ultimately leading t%li%improved health outcomes and cost savings in the healthcare industry. For instance, in January 2024, Eli Lilly introduced LillyDirect, a digital platform designed t%li%streamline purchasing specific medications for patients with prescriptions addressing conditions like diabetes, obesity, and migraine. This platform offers direct access t%li%medicines by linking patients with independent Telehealth providers and providing resources for disease management, eliminating the traditional steps of obtaining a prescription from a physician. In addition, Health Information Exchange (HIE) significantly boosts the eHealth market by promoting interoperability and ensuring seamless data exchange among healthcare entities for improved care coordination.
HIE enhances care continuity by providing comprehensive patient records, leading t%li%faster diagnoses and better outcomes. It streamlines processes, reduces redundancies, and improves efficiency by eliminating manual data entry and repeated tests. HIE empowers patients by allowing them t%li%access and share their health records, contributing t%li%better engagement and decision-making. For instance, in December 2023, a group comprising 21 Ontari%li%hospitals and healthcare facilities launched the Ontari%li%eHub Health Information Exchange (HIE) powered by Oracle Health. This innovative platform enables seamless and secure sharing of patient data among participating healthcare organizations. By leveraging the Ontari%li%eHub, these entities can streamline administrative processes, minimize overhead costs, and enhance care coordination t%li%improve patient healthcare outcomes.
Moreover, the government's initiatives significantly contributed t%li%market growth. For instance, in May 2023, the U.S. Department of Health and Human Services (HHS) announced federal flexibilities regarding telehealth and telemedicine prescriptions t%li%ensure ongoing access t%li%essential care for patients. Initially implemented during the COVID-19 Public Health Emergency (PHE), these flexibilities were extended through the end of 2024 via the Consolidated Appropriations Act of 2023. Key provisions include expanded access t%li%telehealth services nationwide, allowing patients t%li%receive Medicare-covered telehealth visits from their homes, and eliminating the need for travel t%li%healthcare facilities. Furthermore, certain Medicare telehealth consultations can now be conducted using audio-only technology, like telephones, for individuals unable t%li%utilize audi%li%and vide%li%mediums, such as smartphones or computers.
U.S. eHealth Market Report Highlights
U.S. eHealth Market Growth & Trends
The U.S. eHealth market size is expected t%li%reach USD 376.6 billion by 2030, registering a CAGR of 17.6% from 2024 t%li%2030, according t%li%a new report by Grand View Research, Inc. The eHealth market is driven by several key factors, including ongoing technological advancements like telemedicine and AI, increased demand for healthcare services, accelerated adoption due t%li%the COVID-19 pandemic, supportive regulatory frameworks, a shift towards patient-centric care models, the cost-effectiveness of digital solutions, data analytics for patient health management, and improved global connectivity. Furthermore, e-prescription is a notable driver of the eHealth market due t%li%its ability t%li%streamline medication management and improve patient safety. It enables healthcare providers t%li%electronically send accurate and legible prescriptions t%li%pharmacies, reducing errors and enhancing efficiency.
E-prescription systems als%li%facilitate better medication adherence by providing patients convenient access t%li%their prescribed medications and dosage instructions, ultimately leading t%li%improved health outcomes and cost savings in the healthcare industry. For instance, in January 2024, Eli Lilly introduced LillyDirect, a digital platform designed t%li%streamline purchasing specific medications for patients with prescriptions addressing conditions like diabetes, obesity, and migraine. This platform offers direct access t%li%medicines by linking patients with independent Telehealth providers and providing resources for disease management, eliminating the traditional steps of obtaining a prescription from a physician. In addition, Health Information Exchange (HIE) significantly boosts the eHealth market by promoting interoperability and ensuring seamless data exchange among healthcare entities for improved care coordination.
HIE enhances care continuity by providing comprehensive patient records, leading t%li%faster diagnoses and better outcomes. It streamlines processes, reduces redundancies, and improves efficiency by eliminating manual data entry and repeated tests. HIE empowers patients by allowing them t%li%access and share their health records, contributing t%li%better engagement and decision-making. For instance, in December 2023, a group comprising 21 Ontari%li%hospitals and healthcare facilities launched the Ontari%li%eHub Health Information Exchange (HIE) powered by Oracle Health. This innovative platform enables seamless and secure sharing of patient data among participating healthcare organizations. By leveraging the Ontari%li%eHub, these entities can streamline administrative processes, minimize overhead costs, and enhance care coordination t%li%improve patient healthcare outcomes.
Moreover, the government's initiatives significantly contributed t%li%market growth. For instance, in May 2023, the U.S. Department of Health and Human Services (HHS) announced federal flexibilities regarding telehealth and telemedicine prescriptions t%li%ensure ongoing access t%li%essential care for patients. Initially implemented during the COVID-19 Public Health Emergency (PHE), these flexibilities were extended through the end of 2024 via the Consolidated Appropriations Act of 2023. Key provisions include expanded access t%li%telehealth services nationwide, allowing patients t%li%receive Medicare-covered telehealth visits from their homes, and eliminating the need for travel t%li%healthcare facilities. Furthermore, certain Medicare telehealth consultations can now be conducted using audio-only technology, like telephones, for individuals unable t%li%utilize audi%li%and vide%li%mediums, such as smartphones or computers.
U.S. eHealth Market Report Highlights
- Based on products, the healthcare information systems segment held the largest share of 42.0% in 2023. The market growth is attributed t%li%increasing healthcare spending and improvements in IT infrastructure. In addition, the growing need for remote patient monitoring is increasing its adoption
- The providers end use segment accounted for the largest share of 53.1% in 2023, driven by the efficiencies delivered by the eHealth solutions in managing patient workflows and data
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.5. Details of primary research
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.1.1. Approach 1: Commodity flow approach
1.7.2. Volume price analysis (Model 2)
1.7.2.1. Approach 2: Volume price analysis
1.8. Research Scope and Assumptions
1.8.1. List of Secondary Sources
1.8.2. List of Primary Sources
1.8.3. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product Outlook
2.2.2. End Use Outlook
2.3. Competitive Insights
CHAPTER 3. U.S. EHEALTH MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Pricing Analysis Around the Medical Food Market
3.3. Industry Analysis
3.3.1. User Perspective Analysis
3.3.2. Key End Users
3.4. Technology Outlook
3.5. Regulatory Framework
3.6. Market Dynamics
3.6.1. Market Drivers Analysis
3.6.1.1. Increasing need to manage regulatory compliance
3.6.1.2. Rising healthcare costs
3.6.1.3. Increasing prevalence of chronic disease
3.6.1.4. Rising adoption of digital healthcare
3.6.1.5. Growing need for patient-centric healthcare delivery
3.6.2. Market Restraints Analysis
3.6.3. Industry Challenges and Opportunity Analysis
3.7. eHealth Market Analysis Tools
3.7.1. Porter’s Analysis
3.7.1.1. Bargaining power of the suppliers
3.7.1.2. Bargaining power of the buyers
3.7.1.3. Threats of substitution
3.7.1.4. Threats from new entrants
3.7.1.5. Competitive rivalry
3.7.2. PESTEL Analysis
3.7.2.1. Political landscape
3.7.2.2. Economic and Social landscape
3.7.2.3. Technological landscape
3.7.2.4. Environmental landscape
3.7.2.5. Legal landscape
3.8. Major Deals & Strategic Alliances Analysis in the eHealth Industry
3.9. Impact of COVID-19
3.10. Case Study Insights
CHAPTER 4. U.S. EHEALTH MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Definition and Scope
4.2. Product Market Share Analysis, 2023 & 2030
4.3. Segment Dashboard
4.4. eHealth Market: By Product, 2018 to 2030
4.5. Telemedicine
4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.6. Health Information Systems
4.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.6.1.1. Electronic Health Record
4.6.1.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.6.1.2. Electronic Medical Record
4.6.1.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.6.1.3. Patient Engagement Solution
4.6.1.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.6.1.4. Population Health Management
4.6.1.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.7. mHealth
4.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.7.1.1. Monitoring services
4.7.1.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.7.1.2. Diagnosis services
4.7.1.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.7.1.3. Healthcare Systems Strengthening Services
4.7.1.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.7.1.4. Others
4.7.1.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.8. ePharmacy
4.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.9. E-Prescribing
4.9.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.10. Computerized Physician Order Entry
4.10.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
CHAPTER 5. U.S. EHEALTH MARKET: END USE ESTIMATES& TREND ANALYSIS
5.1. Definition and Scope
5.2. End Use Market Share Analysis, 2023 & 2030
5.3. Segment Dashboard
5.4. eHealth Market: By End Use, 2018 to 2030
5.5. Providers
5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.6. Payers
5.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.7. Patients
5.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Recent Developments & Impact Analysis by Key Market Participants
6.2. Company Categorization
6.3. Company Market Share Analysis
6.4. Company Heat Map Analysis
6.5. Strategy Mapping
6.5.1. Expansion
6.5.2. Mergers & Acquisition
6.5.3. Partnerships & Collaborations
6.5.4. New Product Launches
6.5.5. Research And Development
6.6. Company Profiles
6.6.1. CVS Health
6.6.1.1. Participant’s Overview
6.6.1.2. Financial Performance
6.6.1.3. Product Benchmarking
6.6.1.4. Recent Developments
6.6.2. Teladoc Health, Inc.
6.6.2.1. Participant’s Overview
6.6.2.2. Financial Performance
6.6.2.3. Product Benchmarking
6.6.2.4. Recent Developments
6.6.3. American Well
6.6.3.1. Participant’s Overview
6.6.3.2. Financial Performance
6.6.3.3. Product Benchmarking
6.6.3.4. Recent Developments
6.6.4. Veradigm LLC
6.6.4.1. Participant’s Overview
6.6.4.2. Financial Performance
6.6.4.3. Product Benchmarking
6.6.4.4. Recent Developments
6.6.5. UNITEDHEALTH GROUP
6.6.5.1. Participant’s Overview
6.6.5.2. Financial Performance
6.6.5.3. Product Benchmarking
6.6.5.4. Recent Developments
6.6.6. Medtronic
6.6.6.1. Participant’s Overview
6.6.6.2. Financial Performance
6.6.6.3. Product Benchmarking
6.6.6.4. Recent Developments
6.6.7. Epocrates
6.6.7.1. Participant’s Overview
6.6.7.2. Financial Performance
6.6.7.3. Product Benchmarking
6.6.7.4. Recent Developments
6.6.8. Telecare Corporation
6.6.8.1. Participant’s Overview
6.6.8.2. Financial Performance
6.6.8.3. Product Benchmarking
6.6.8.4. Recent Developments
6.6.9. Medisafe
6.6.9.1. Participant’s Overview
6.6.9.2. Financial Performance
6.6.9.3. Product Benchmarking
6.6.9.4. Recent Developments
6.6.10. Set Point Medical
6.6.10.1. Participant’s Overview
6.6.10.2. Financial Performance
6.6.10.3. Product Benchmarking
6.6.10.4. Recent Developments
6.6.11. IBM
6.6.11.1. Participant’s Overview
6.6.11.2. Financial Performance
6.6.11.3. Product Benchmarking
6.6.11.4. Recent Developments
6.6.12. Doximity, Inc.
6.6.12.1. Participant’s Overview
6.6.12.2. Financial Performance
6.6.12.3. Product Benchmarking
6.6.12.4. Recent Developments
6.6.13. LiftLabs
6.6.13.1. Participant’s Overview
6.6.13.2. Financial Performance
6.6.13.3. Product Benchmarking
6.6.13.4. Recent Developments
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.5. Details of primary research
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.1.1. Approach 1: Commodity flow approach
1.7.2. Volume price analysis (Model 2)
1.7.2.1. Approach 2: Volume price analysis
1.8. Research Scope and Assumptions
1.8.1. List of Secondary Sources
1.8.2. List of Primary Sources
1.8.3. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product Outlook
2.2.2. End Use Outlook
2.3. Competitive Insights
CHAPTER 3. U.S. EHEALTH MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Pricing Analysis Around the Medical Food Market
3.3. Industry Analysis
3.3.1. User Perspective Analysis
3.3.2. Key End Users
3.4. Technology Outlook
3.5. Regulatory Framework
3.6. Market Dynamics
3.6.1. Market Drivers Analysis
3.6.1.1. Increasing need to manage regulatory compliance
3.6.1.2. Rising healthcare costs
3.6.1.3. Increasing prevalence of chronic disease
3.6.1.4. Rising adoption of digital healthcare
3.6.1.5. Growing need for patient-centric healthcare delivery
3.6.2. Market Restraints Analysis
3.6.3. Industry Challenges and Opportunity Analysis
3.7. eHealth Market Analysis Tools
3.7.1. Porter’s Analysis
3.7.1.1. Bargaining power of the suppliers
3.7.1.2. Bargaining power of the buyers
3.7.1.3. Threats of substitution
3.7.1.4. Threats from new entrants
3.7.1.5. Competitive rivalry
3.7.2. PESTEL Analysis
3.7.2.1. Political landscape
3.7.2.2. Economic and Social landscape
3.7.2.3. Technological landscape
3.7.2.4. Environmental landscape
3.7.2.5. Legal landscape
3.8. Major Deals & Strategic Alliances Analysis in the eHealth Industry
3.9. Impact of COVID-19
3.10. Case Study Insights
CHAPTER 4. U.S. EHEALTH MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Definition and Scope
4.2. Product Market Share Analysis, 2023 & 2030
4.3. Segment Dashboard
4.4. eHealth Market: By Product, 2018 to 2030
4.5. Telemedicine
4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.6. Health Information Systems
4.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.6.1.1. Electronic Health Record
4.6.1.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.6.1.2. Electronic Medical Record
4.6.1.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.6.1.3. Patient Engagement Solution
4.6.1.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.6.1.4. Population Health Management
4.6.1.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.7. mHealth
4.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.7.1.1. Monitoring services
4.7.1.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.7.1.2. Diagnosis services
4.7.1.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.7.1.3. Healthcare Systems Strengthening Services
4.7.1.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.7.1.4. Others
4.7.1.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.8. ePharmacy
4.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.9. E-Prescribing
4.9.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.10. Computerized Physician Order Entry
4.10.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
CHAPTER 5. U.S. EHEALTH MARKET: END USE ESTIMATES& TREND ANALYSIS
5.1. Definition and Scope
5.2. End Use Market Share Analysis, 2023 & 2030
5.3. Segment Dashboard
5.4. eHealth Market: By End Use, 2018 to 2030
5.5. Providers
5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.6. Payers
5.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.7. Patients
5.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Recent Developments & Impact Analysis by Key Market Participants
6.2. Company Categorization
6.3. Company Market Share Analysis
6.4. Company Heat Map Analysis
6.5. Strategy Mapping
6.5.1. Expansion
6.5.2. Mergers & Acquisition
6.5.3. Partnerships & Collaborations
6.5.4. New Product Launches
6.5.5. Research And Development
6.6. Company Profiles
6.6.1. CVS Health
6.6.1.1. Participant’s Overview
6.6.1.2. Financial Performance
6.6.1.3. Product Benchmarking
6.6.1.4. Recent Developments
6.6.2. Teladoc Health, Inc.
6.6.2.1. Participant’s Overview
6.6.2.2. Financial Performance
6.6.2.3. Product Benchmarking
6.6.2.4. Recent Developments
6.6.3. American Well
6.6.3.1. Participant’s Overview
6.6.3.2. Financial Performance
6.6.3.3. Product Benchmarking
6.6.3.4. Recent Developments
6.6.4. Veradigm LLC
6.6.4.1. Participant’s Overview
6.6.4.2. Financial Performance
6.6.4.3. Product Benchmarking
6.6.4.4. Recent Developments
6.6.5. UNITEDHEALTH GROUP
6.6.5.1. Participant’s Overview
6.6.5.2. Financial Performance
6.6.5.3. Product Benchmarking
6.6.5.4. Recent Developments
6.6.6. Medtronic
6.6.6.1. Participant’s Overview
6.6.6.2. Financial Performance
6.6.6.3. Product Benchmarking
6.6.6.4. Recent Developments
6.6.7. Epocrates
6.6.7.1. Participant’s Overview
6.6.7.2. Financial Performance
6.6.7.3. Product Benchmarking
6.6.7.4. Recent Developments
6.6.8. Telecare Corporation
6.6.8.1. Participant’s Overview
6.6.8.2. Financial Performance
6.6.8.3. Product Benchmarking
6.6.8.4. Recent Developments
6.6.9. Medisafe
6.6.9.1. Participant’s Overview
6.6.9.2. Financial Performance
6.6.9.3. Product Benchmarking
6.6.9.4. Recent Developments
6.6.10. Set Point Medical
6.6.10.1. Participant’s Overview
6.6.10.2. Financial Performance
6.6.10.3. Product Benchmarking
6.6.10.4. Recent Developments
6.6.11. IBM
6.6.11.1. Participant’s Overview
6.6.11.2. Financial Performance
6.6.11.3. Product Benchmarking
6.6.11.4. Recent Developments
6.6.12. Doximity, Inc.
6.6.12.1. Participant’s Overview
6.6.12.2. Financial Performance
6.6.12.3. Product Benchmarking
6.6.12.4. Recent Developments
6.6.13. LiftLabs
6.6.13.1. Participant’s Overview
6.6.13.2. Financial Performance
6.6.13.3. Product Benchmarking
6.6.13.4. Recent Developments
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 U.S. ehealth market, by Product, 2018 - 2030 (USD Million)
Table 4 U.S. ehealth market, by end use, 2018 - 2030 (USD Million)
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 U.S. ehealth market, by Product, 2018 - 2030 (USD Million)
Table 4 U.S. ehealth market, by end use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Sacroiliac joint fusion surgery market: outlook
Fig. 9 Sacroiliac joint fusion surgery competitive insights
Fig. 10 Ancillary market outlook
Fig. 11 Sacroiliac joint fusion surgery market driver impact
Fig. 12 Sacroiliac joint fusion surgery market restraint impact
Fig. 13 Porter’s Analysis
Fig. 14 PESTLE Analysis
Fig. 15 Sacroiliac joint fusion surgery market: Indication movement analysis
Fig. 16 Sacroiliac joint fusion surgery market: Indication outlook and key takeaways
Fig. 17 Degenerative sacroiliitis market estimates and forecast, 2018 - 2030
Fig. 18 Sacral disruption market estimates and forecast, 2018 - 2030
Fig. 19 Trauma market estimates and forecast, 2018 - 2030
Fig. 20 Sacroiliac joint fusion surgery Market: Type movement Analysis
Fig. 21 Sacroiliac joint fusion surgery market: Type outlook and key takeaways
Fig. 22 MIS market estimates and forecasts, 2018 - 2030
Fig. 23 Open market estimates and forecasts,2018 - 2030
Fig. 24 Sacroiliac joint fusion surgery Market: Approach movement Analysis
Fig. 25 Sacroiliac joint fusion surgery market: Approach outlook and key takeaways
Fig. 26 Dorsal & anterior market estimates and forecasts, 2018 - 2030
Fig. 27 Lateral market estimates and forecasts,2018 - 2030
Fig. 28 Sacroiliac joint fusion surgery Market: Product movement Analysis
Fig. 29 Sacroiliac joint fusion surgery market: Product outlook and key takeaways
Fig. 30 Implants market estimates and forecasts, 2018 - 2030
Fig. 31 Accessories market estimates and forecasts,2018 - 2030
Fig. 32 Sacroiliac joint fusion surgery Market: End use movement Analysis
Fig. 33 Sacroiliac joint fusion surgery market: End use outlook and key takeaways
Fig. 34 Hospitals market estimates and forecasts, 2018 - 2030
Fig. 35 Ambulatory surgical centers market estimates and forecasts,2018 - 2030
Fig. 36 Others market estimates and forecasts,2018 - 2030
Fig. 37 Global sacroiliac joint fusion surgery market: Regional movement analysis
Fig. 38 Global sacroiliac joint fusion surgery market: Regional outlook and key takeaways
Fig. 39 North America sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Key country dynamics
Fig. 41 U.S. sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Key country dynamics
Fig. 43 Canada sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Key country dynamics
Fig. 45 Mexico sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Europe sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Key country dynamics
Fig. 48 UK sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Key country dynamics
Fig. 50 Germany sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Key country dynamics
Fig. 52 Spain sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Key country dynamics
Fig. 54 France sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Key country dynamics
Fig. 56 Italy sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Key country dynamics
Fig. 58 Norway sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 Denmark sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 Sweden sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Asia Pacific sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Key country dynamics
Fig. 65 Japan sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Key country dynamics
Fig. 67 China sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Key country dynamics
Fig. 69 India sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Key country dynamics
Fig. 71 Australia sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 South Korea sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 Thailand sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Latin America sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 Brazil sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 Argentina sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 MEA sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 Key country dynamics
Fig. 83 South Africa sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 84 Key country dynamics
Fig. 85 Saudi Arabia sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Key country dynamics
Fig. 87 UAE sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 88 Key country dynamics
Fig. 89 Kuwait sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 90 Key company categorization
Fig. 91 Heat map analysis, 2022 - 2023
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Sacroiliac joint fusion surgery market: outlook
Fig. 9 Sacroiliac joint fusion surgery competitive insights
Fig. 10 Ancillary market outlook
Fig. 11 Sacroiliac joint fusion surgery market driver impact
Fig. 12 Sacroiliac joint fusion surgery market restraint impact
Fig. 13 Porter’s Analysis
Fig. 14 PESTLE Analysis
Fig. 15 Sacroiliac joint fusion surgery market: Indication movement analysis
Fig. 16 Sacroiliac joint fusion surgery market: Indication outlook and key takeaways
Fig. 17 Degenerative sacroiliitis market estimates and forecast, 2018 - 2030
Fig. 18 Sacral disruption market estimates and forecast, 2018 - 2030
Fig. 19 Trauma market estimates and forecast, 2018 - 2030
Fig. 20 Sacroiliac joint fusion surgery Market: Type movement Analysis
Fig. 21 Sacroiliac joint fusion surgery market: Type outlook and key takeaways
Fig. 22 MIS market estimates and forecasts, 2018 - 2030
Fig. 23 Open market estimates and forecasts,2018 - 2030
Fig. 24 Sacroiliac joint fusion surgery Market: Approach movement Analysis
Fig. 25 Sacroiliac joint fusion surgery market: Approach outlook and key takeaways
Fig. 26 Dorsal & anterior market estimates and forecasts, 2018 - 2030
Fig. 27 Lateral market estimates and forecasts,2018 - 2030
Fig. 28 Sacroiliac joint fusion surgery Market: Product movement Analysis
Fig. 29 Sacroiliac joint fusion surgery market: Product outlook and key takeaways
Fig. 30 Implants market estimates and forecasts, 2018 - 2030
Fig. 31 Accessories market estimates and forecasts,2018 - 2030
Fig. 32 Sacroiliac joint fusion surgery Market: End use movement Analysis
Fig. 33 Sacroiliac joint fusion surgery market: End use outlook and key takeaways
Fig. 34 Hospitals market estimates and forecasts, 2018 - 2030
Fig. 35 Ambulatory surgical centers market estimates and forecasts,2018 - 2030
Fig. 36 Others market estimates and forecasts,2018 - 2030
Fig. 37 Global sacroiliac joint fusion surgery market: Regional movement analysis
Fig. 38 Global sacroiliac joint fusion surgery market: Regional outlook and key takeaways
Fig. 39 North America sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Key country dynamics
Fig. 41 U.S. sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Key country dynamics
Fig. 43 Canada sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Key country dynamics
Fig. 45 Mexico sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Europe sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Key country dynamics
Fig. 48 UK sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Key country dynamics
Fig. 50 Germany sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Key country dynamics
Fig. 52 Spain sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Key country dynamics
Fig. 54 France sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Key country dynamics
Fig. 56 Italy sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Key country dynamics
Fig. 58 Norway sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 Denmark sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 Sweden sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Asia Pacific sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Key country dynamics
Fig. 65 Japan sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Key country dynamics
Fig. 67 China sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Key country dynamics
Fig. 69 India sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Key country dynamics
Fig. 71 Australia sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 South Korea sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 Thailand sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Latin America sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 Brazil sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 Argentina sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 MEA sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 Key country dynamics
Fig. 83 South Africa sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 84 Key country dynamics
Fig. 85 Saudi Arabia sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Key country dynamics
Fig. 87 UAE sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 88 Key country dynamics
Fig. 89 Kuwait sacroiliac joint fusion surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 90 Key company categorization
Fig. 91 Heat map analysis, 2022 - 2023
